Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.12 AUD | -4.00% | 0.00% | -29.41% |
Apr. 08 | Starpharma, Medicxi Co-Found Petalion Therapeutics; Shares Surge 16% | MT |
Mar. 18 | Starpharma Holdings Limited(ASX:SPL) dropped from S&P/ASX Emerging Companies Index | CI |
Sales 2022 | 5.16M 3.41M | Sales 2023 | 4.21M 2.78M | Capitalization | 127M 84M |
---|---|---|---|---|---|
Net income 2022 | -16M -10.56M | Net income 2023 | -15M -9.9M | EV / Sales 2022 | 50.5 x |
Net cash position 2022 | 41.73M 27.55M | Net cash position 2023 | 26.91M 17.76M | EV / Sales 2023 | 23.8 x |
P/E ratio 2022 |
-18.5
x | P/E ratio 2023 |
-7.75
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 92.68% |
1 day | -4.00% | ||
Current month | -4.00% | ||
1 month | -17.24% | ||
3 months | -20.00% | ||
6 months | -14.29% | ||
Current year | -29.41% |
Managers | Title | Age | Since |
---|---|---|---|
Cheryl Maley
CEO | Chief Executive Officer | - | Jan. 07 |
Justin Cahill
DFI | Director of Finance/CFO | - | 23-04-02 |
Tony Eglezos
PRN | Corporate Officer/Principal | - | 13-08-11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeff Davies
BRD | Director/Board Member | - | 22-03-31 |
Robert Thomas
CHM | Chairman | 79 | 13-12-03 |
David McIntyre
BRD | Director/Board Member | 53 | 20-02-29 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 0.12 | -4.00% | 647,310 |
24-05-09 | 0.125 | 0.00% | 417,600 |
24-05-08 | 0.125 | +4.17% | 801,047 |
24-05-07 | 0.12 | -4.00% | 289,983 |
24-05-06 | 0.125 | +4.17% | 76,190 |
Delayed Quote Australian S.E., May 10, 2024 at 02:10 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-29.41% | 32.65M | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- SPL Stock